Motley Fool Asset Management LLC Gilead Sciences, Inc. Transaction History
Motley Fool Asset Management LLC
- $1.46 Billion
- Q2 2024
A detailed history of Motley Fool Asset Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Motley Fool Asset Management LLC holds 55,077 shares of GILD stock, worth $4.86 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
55,077
Previous 42,577
29.36%
Holding current value
$4.86 Million
Previous $3.12 Million
21.17%
% of portfolio
0.26%
Previous 0.22%
Shares
27 transactions
Others Institutions Holding GILD
# of Institutions
1,895Shares Held
1.02BCall Options Held
12MPut Options Held
9.02M-
Black Rock Inc. New York, NY121MShares$10.7 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.2 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$6.73 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$5.34 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$5.24 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $111B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...